21 results
Anaphylaxis: Treatments (Acute)
Additional Info:
 • IV steroids may be considered for prevention of late phase reactions.
Anaphylaxis: Treatments ... of late phase reactions ... Treatment: • ... #Management #pathophysiology ... #immunology
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... indicate preferred treatment ... LAMA: long-acting ... #Management #Pulmonary
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Medical Treatment ... Algorithm for Chronic ... Initial medical treatment ... #Algorithm #Management ... SABA #SAMA #ICS #Pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Penicilliosis #IDSA ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Algorithm for the Management of Purulent skin and soft tissue infections (SSTIs). 
Mild infection: for
IDSA Algorithm for ... the Management ... 12 000 or <400 cells ... oral antibiotic treatment ... #SSTIs #Algorithm
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... Infection General Management ... IsosporaBelli #IDSA ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
Insomnia Management

 • What is insomnia?
 • Pathophysiology
 • Risk Factors
 • Diagnosis
 • Drugs producing
Pathophysiology ... Hygiene • Non-Drug Treatment ... • Pharmacologic ... Treatment Options ... #treatment
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... Tuberculosis #MDRTB #management ... #regimens #pharmacology ... #dosing #idsa #
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... CD4 count <200 cells ... Leishmaniasis #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... CD4 count <100 cells ... #Prevention #Treatment ... infections #HIVAIDS #management ... pharmacology